Free tool
DLHAX and FHLC: how much do they overlap?
Enter any two ETFs or mutual funds to see how much of their portfolios overlap, using each fund's latest SEC holdings report.
Bottom line
Overlap between DLHAX and FHLC
39% of their top holdings overlap by weight, with 11 securities in common among each fund's top 25. They share a meaningful core but differ in the rest of the portfolio. Note that FHLC holds far more positions (337 vs 108), so it is broader beyond the top names.
| Holding | % of DLHAX | % of FHLC |
|---|---|---|
| Abbvie Inc | 4.19% | 6.42% |
| Eli Lilly & Company | 4.16% | 13.35% |
| Regeneron Pharmaceuticals Inc | 3.91% | 1.15% |
| Unitedhealth Group Inc | 3.88% | 5.44% |
| Pfizer Inc | 3.84% | 2.06% |
| Merck & Company Inc | 3.68% | 4.66% |
| Gilead Sciences Inc | 3.54% | 2.34% |
| Elevance Health Inc | 3.25% | 1.19% |
| Amgen Inc | 2.27% | 3.00% |
| Vertex Pharmaceuticals Inc | 1.66% | 1.76% |
| Boston Scientific Corp | 1.42% | 1.00% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Popular overlap checks
| Pair | Overlap | |
|---|---|---|
| VOO vs VTI | 99% | Details |
| QQQ vs VGT | 57% | Details |
| SCHD vs VYM | 24% | Details |
| VOO vs QQQ | 68% | Details |
| VTI vs VXUS | 0% | Details |
| VUG vs QQQ | 69% | Details |
| JEPI vs SCHD | 2% | Details |
Source: SEC Form N-PORT; top-25 holdings, weight-normalized